Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prognostic impact of sarcopenia in patients with head and neck cancer treated with surgery or radiation: A meta-analysis
Yukinori Takenaka, Norihiko Takemoto, Ryohei Oya, et al.
PLoS ONE (2021) Vol. 16, Iss. 10, pp. e0259288-e0259288
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Role of sarcopenia on survival and treatment-related toxicity in head and neck cancer: a narrative review of current evidence and future perspectives
Enes Erul, Deniz Can Güven, Mehmet Ruhi Onur, et al.
European Archives of Oto-Rhino-Laryngology (2023) Vol. 280, Iss. 8, pp. 3541-3556
Closed Access | Times Cited: 21
Measurement of Sarcopenia in Head and Neck Cancer Patients and Its Association With Frailty
Remco de Bree, C Meerkerk, György B. Halmos, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 26
Sarcopenia and its impact in head and neck cancer treatment
Remco de Bree, Maartje A. van Beers, Anouk W. M. A. Schaeffers
Current Opinion in Otolaryngology & Head & Neck Surgery (2022) Vol. 30, Iss. 2, pp. 87-93
Open Access | Times Cited: 23
Effect of Sarcopenia on Swallowing in Patients With Head and Neck Cancer
Angela A. Colback, Daniel V. Arkfeld, Lisa Evangelista, et al.
Otolaryngology (2024) Vol. 170, Iss. 5, pp. 1331-1337
Open Access | Times Cited: 5
Evaluation of Sarcopenia As A Prognostic Biomarker in Locally Advanced Head and Neck Squamous Cell Carcinoma
Enes Erul, Deniz Can Güven, Yakup Özbay, et al.
Biomarkers in Medicine (2023) Vol. 17, Iss. 2, pp. 87-99
Closed Access | Times Cited: 11
Biochemical Markers of Sarcopenia as Predictors of Outcomes Among Patients Undergoing Laryngectomy
Marianne Abouyared, Angela A. Colback, Alexander Jones, et al.
Head & Neck (2025)
Closed Access
Sarcopenic obesity in patients with head and neck cancer is predictive of critical weight loss during radiotherapy
Belinda Vangelov, Robert I. Smee, Judith Bauer
British Journal Of Nutrition (2024), pp. 1-8
Closed Access | Times Cited: 3
Enhanced recovery after surgery, current, and future considerations in head and neck cancer
Marna A. List, Mark Knackstedt, Lucy Liu, et al.
Laryngoscope Investigative Otolaryngology (2023) Vol. 8, Iss. 5, pp. 1240-1256
Open Access | Times Cited: 6
Predictive significance of body composition indices in patients with head and neck squamous cell carcinoma treated with nivolumab: A multicenter retrospective study
Yukinori Takenaka, Norihiko Takemoto, Tomoyuki Otsuka, et al.
Oral Oncology (2022) Vol. 132, pp. 106018-106018
Closed Access | Times Cited: 10
Cut-off values for low skeletal muscle mass at the level of the third cervical vertebra (C3) in patients with head and neck cancer
Najiba Chargi, Sandra I. Bril, Ernst J. Smid, et al.
Quantitative Imaging in Medicine and Surgery (2022) Vol. 12, Iss. 6, pp. 3024-3033
Open Access | Times Cited: 9
Statin Medication Improves Five-Year Survival Rates in Patients with Head and Neck Cancer: A Retrospective Case-Control Study of about 100,000 Patients
Jonas Wüster, Max Heiland, Susanne Nahles, et al.
Cancers (2023) Vol. 15, Iss. 12, pp. 3093-3093
Open Access | Times Cited: 5
Untailored vs. Gender- and Body-Mass-Index-Tailored Skeletal Muscle Mass Index (SMI) to Assess Sarcopenia in Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)
Cristina Morelli, Vincenzo Formica, Paolo Bossi, et al.
Cancers (2023) Vol. 15, Iss. 19, pp. 4716-4716
Open Access | Times Cited: 5
Impact and Treatment of Sarcopenia in Patients Undergoing Radiotherapy: A Multidisciplinary, AMSTAR-2 Compliant Review of Systematic Reviews and Metanalyses
Federica Medici, Alberto Bazzocchi, Milly Buwenge, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 8
Effect of Pre-Existing Sarcopenia on Oncological Outcomes for Oral Cavity Squamous Cell Carcinoma Undergoing Curative Surgery: A Propensity Score-Matched, Nationwide, Population-Based Cohort Study
Yu‐Hsiang Tsai, Wan‐Ming Chen, Mingchih Chen, et al.
Cancers (2022) Vol. 14, Iss. 13, pp. 3246-3246
Open Access | Times Cited: 8
Impact of low skeletal muscle mass and quality on clinical outcomes in patients with head and neck cancer undergoing (chemo)radiation
Lilia Bardoscia, Giulia Besutti, Massimo Pellegrini, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 8
Multi-Domain Screening: Identification of Patient’s Risk Profile Prior to Head-and-Neck Cancer Treatment
Monse W. M. Wieland, Walmari Pilz, Björn Winkens, et al.
Cancers (2023) Vol. 15, Iss. 21, pp. 5254-5254
Open Access | Times Cited: 4
The impact of sarcopenia in the treatment for patients with head and neck cancer
Mutsukazu Kitano, Ryuji Yasumatsu
Auris Nasus Larynx (2024) Vol. 51, Iss. 4, pp. 717-723
Closed Access | Times Cited: 1
Everything You Always Wanted to Know about Sarcopenia but Were Afraid to Ask: A Quick Guide for Radiation Oncologists (impAct oF saRcopeniA In raDiotherapy: The AFRAID Project)
Federica Medici, Stefania Rizzo, Milly Buwenge, et al.
Current Oncology (2022) Vol. 29, Iss. 11, pp. 8513-8528
Open Access | Times Cited: 6
Low skeletal muscle mass is predictive of dose-limiting toxicities in head and neck cancer patients undergoing low-dose weekly cisplatin chemoradiotherapy
Jan-Niklas Becker, Robert Michael Hermann, Jörn Wichmann, et al.
PLoS ONE (2023) Vol. 18, Iss. 2, pp. e0282015-e0282015
Open Access | Times Cited: 3
Prognostic value of pretreatment skeletal muscle index in pancreatic carcinoma patients: A meta-analysis
Yang Li, Xianghui Liao, Zhong Xie, et al.
Medicine (2023) Vol. 102, Iss. 19, pp. e33663-e33663
Open Access | Times Cited: 3
Investigating sarcopenia, physical activity, and inflammation biomarkers in newly diagnosed oral cancer patients undergoing curative treatment: A prospective longitudinal study
Chun-Hou Huang, Tai‐Chu Peng, Yu‐Fu Chou, et al.
Asia-Pacific Journal of Oncology Nursing (2023) Vol. 10, Iss. 8, pp. 100261-100261
Open Access | Times Cited: 2
Prophylactic pectoralis major flap to compensate for increased risk of pharyngocutaneous fistula in laryngectomy patients with low skeletal muscle mass (PECTORALIS): study protocol for a randomized controlled trial
Maartje A. van Beers, Caroline M. Speksnijder, Carla H. van Gils, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access
Discrete prognostic implication of sarcopenia according to nutritional status in surgically treated patients with hypopharyngeal cancer
Junyong Go, Yoon Se Lee, Young Jun Choi, et al.
World Journal of Surgery (2024) Vol. 48, Iss. 8, pp. 1892-1901
Open Access
Changes in serum lactate dehydrogenase as a prognostic factor in patients with head and neck squamous cell carcinoma treated with immune checkpoint inhibitors
Woo Hee Lee, Yukinori Takenaka, Kiyohito Hosokawa, et al.
Acta Oto-Laryngologica (2024) Vol. 144, Iss. 5-6, pp. 398-403
Closed Access
Head and Neck Cancer and Sarcopenia: An Integrative Clinical and Functional Review
Kazuhira Endo, Mariko Ichinose, Eiji Kobayashi, et al.
Cancers (2024) Vol. 16, Iss. 20, pp. 3460-3460
Open Access
Page 1 - Next Page

Scroll to top